# Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Liver Insufficiency and Normal Liver Function

> **NCT07144098** · PHASE1 · RECRUITING · sponsor: **Gan & Lee Pharmaceuticals.** · enrollment: 24 (estimated)

## Conditions studied

- Obesity/Overweight

## Interventions

- **DRUG:** GZR18 injection
- **DRUG:** GZR18 injection
- **DRUG:** GZR18 injection
- **DRUG:** GZR18 injection

## Key facts

- **NCT ID:** NCT07144098
- **Lead sponsor:** Gan & Lee Pharmaceuticals.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-12
- **Primary completion:** 2026-07-12
- **Final completion:** 2027-01-26
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07144098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07144098, "Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Liver Insufficiency and Normal Liver Function". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07144098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*